U.S. Market for Magnetic Resonance, Computed Tomography and Nuclear Medicine 2010

Date: December 22, 2010
Pages: 149
Price:
US$ 7,495.00
License [?]:
Publisher: iData Research Inc.
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery
ID: UB6E389CC8FEN
Leaflet:

Download PDF Leaflet

U.S. Market for Magnetic Resonance, Computed Tomography and Nuclear Medicine 2010
In 2009, the U.S. market for magnetic resonance (MRI), computed tomography (CT) and nuclear medicine was valued at over $5.1 billion. This market also includes contrast agents and injectors. The market declined in 2009 due to the deficit reduction act, which limited reimbursement for some imaging modalities, and the global economic recession of 2008 to 2009; however, the market is expected to recover by 2016.

This market includes:

Magnetic Resonance Imaging (MRI):
  • Low-Field Magnetic Resonance Imaging
  • Mid-Field Magnetic Resonance Imaging
  • High-Field Magnetic Resonance Imaging
  • Open Magnetic Resonance Imaging
  • Intraoperative Magnetic Resonance Imaging

Computed Tomography (CT):
  • 16/20 Slice Computed Tomography
  • 32/40 Slice Computed Tomography
  • 64 Slice Computed Tomography
  • Ultra Premium Computed Tomography

Nuclear Medicine:
  • Ultra Premium Computed Tomography
  • PET/CT
  • SPECT
  • SPECT/CT

Contrast Agents and Injectors:
  • X-Ray/CT Contrast Agents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • Contrast Injectors

Within the magnetic resonance (MRI), computed tomography (CT) and nuclear medicine markets, companies such as Bracco, Covidien, GE Healthcare, Philips Healthcare and Siemens Healthcare lead the market. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.
EXECUTIVE SUMMARY

1.1 TOTAL U.S. MAGNETIC RESONANCE, COMPUTED TOMOGRAPHY AND NUCLEAR MEDICINE MARKET
1.2 LOW-FIELD MAGNETIC RESONANCE IMAGING MARKET
1.3 MID-FIELD MAGNETIC RESONANCE IMAGING MARKET
1.4 HIGH-FIELD MAGNETIC RESONANCE IMAGING MARKET
1.5 OPEN-FIELD MAGNETIC RESONANCE IMAGING MARKET
1.6 INTRA-OPERATIVE MAGNETIC RESONANCE IMAGING MARKET
1.7 16/20 SLICE COMPUTED TOMOGRAPHY MARKET
1.8 32/40 SLICE COMPUTED TOMOGRAPHY MARKET
1.9 64 SLICE COMPUTED TOMOGRAPHY MARKET
1.10 ULTRA PREMIUM COMPUTED TOMOGRAPHY MARKET
1.11 POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY MARKET
1.12 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET
1.13 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY/COMPUTED TOMOGRAPHY MARKET
1.14 CONTRAST AGENT AND INJECTOR MARKET
1.15 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

U.S. MAGNETIC RESONANCE IMAGING, COMPUTED TOMOGRAPHY AND NUCLEAR MEDICINE MARKET

3.1 INTRODUCTION
  3.1.1 Magnetic Resonance Imaging
  3.1.2 Computed Tomography
  3.1.3 Nuclear Medicine
  3.1.4 Contrast Agents and Injectors
3.2 MARKET OVERVIEW
3.3 MARKET BY SEGMENT
3.4 TREND ANALYSIS BY SEGMENT
3.5 MARKET DRIVERS AND LIMITERS
  3.5.1 Market Drivers
  3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS

MAGNETIC RESONANCE IMAGING MARKET

4.1 INTRODUCTION
4.2 PROCEDURE NUMBERS
4.3 MARKET OVERVIEW
4.4 MARKET ANALYSIS AND FORECAST
  4.4.1 Low-Field Magnetic Resonance Imaging Market
  4.4.2 Mid-Field Magnetic Resonance Imaging Market
  4.4.3 High-Field Magnetic Resonance Imaging Market
  4.4.4 Open Magnetic Resonance Imaging Market
  4.4.5 Intraoperative Magnetic Resonance Imaging Market
4.5 MARKET DRIVERS AND LIMITERS
  4.5.1 Market Drivers
  4.5.2 Market Limiters
4.6 COMPETITIVE ANALYSIS

COMPUTED TOMOGRAPHY IMAGING MARKET

5.1 INTRODUCTION
5.2 PROCEDURE NUMBERS
5.3 MARKET OVERVIEW
5.4 MARKET ANALYSIS AND FORECAST
  5.4.1 16/20 Slice Computed Tomography Market
  5.4.2 32/40 Slice Computed Tomography Market
  5.4.3 64 Slice Computed Tomography Market
  5.4.4 Ultra Premium Computed Tomography Market
5.5 MARKET DRIVERS AND LIMITERS
  5.5.1 Market Drivers
  5.5.2 Market Limiters
5.6 COMPETITIVE ANALYSIS

NUCLEAR MEDICINE IMAGING MARKET

6.1 INTRODUCTION
6.2 PROCEDURE NUMBERS
6.3 MARKET OVERVIEW
6.4 MARKET ANALYSIS AND FORECAST
  6.4.1 PET/CT Market
  6.4.2 SPECT Market
  6.4.3 SPECT/CT Market
6.5 MARKET DRIVERS AND LIMITERS
  6.5.1 Market Drivers
  6.5.2 Market Limiters
6.6 COMPETITIVE ANALYSIS

CONTRAST AGENT AND INJECTOR MARKET

7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
  7.3.1 X-Ray/CT Contrast Agent Market
  7.3.2 MRI Contrast Agent Market
  7.3.3 Ultrasound Contrast Agent Market
  7.3.4 Contrast Injector Market
7.4 MARKET DRIVERS AND LIMITERS
  7.4.1 Market Drivers
  7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

U.S. MAGNETIC RESONANCE IMAGING, COMPUTED TOMOGRAPHY AND NUCLEAR MEDICINE MARKET

Figure 3-1: Total MRI, CT and Nuclear Medicine Market, U.S., 2006 – 2016
Figure 3-2: MRI, CT and Nuclear Medicine Market by Segment, U.S., 2006 – 2016 (Part 1 of 2)
Figure 3-3: Total MRI, CT and Nuclear Medicine Market by Segment, U.S., 2006 – 2016 (Part 2 of 2)
Figure 3-4: Growth Rates by Segment, Total MRI, CT and Nuclear Medicine Market, U.S., 2006 – 2016 (Part 1 of 2)
Figure 3-5: Growth Rates by Segment, Total MRI, CT and Nuclear Medicine Market, U.S., 2006 – 2016 (Part 2 of 2)
Figure 3-6: Drivers and Limiters, MRI, CT and Nuclear Medicine Market, 2009
Figure 3-7: Leading Competitors, MRI, CT and Nuclear Medicine Market, 2009 (Part 1 of 2)
Figure 3-8: Leading Competitors, MRI, CT and Nuclear Medicine Market, 2009 (Part 2 of 2)

MAGNETIC RESONANCE IMAGING MARKET

Figure 4-1: Total Magnetic Resonance Procedures, U.S., 2006 – 2016
Figure 4-2: Total Magnetic Resonance Imaging Market by Segment, U.S., 2006 – 2016
Figure 4-3: Total Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Figure 4-4: Low-Field Magnetic Resonance Imaging Market, U.S., 2006 – 2016 .
Figure 4-5: Mid-Field Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Figure 4-6: High-Field Magnetic Resonance Imaging Market, U.S., 2006 – 2016.
Figure 4-7: Open Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Figure 4-8: Intraoperative Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Figure 4-9: Drivers and Limiters, Magnetic Resonance Imaging Market, 2009
Figure 4-10: Leading Competitors, Magnetic Resonance Imaging Market, 2009

COMPUTED TOMOGRAPHY IMAGING MARKET

Figure 5-1: Total Computed Tomography Procedures, U.S., 2006 – 2016
Figure 5-2: Total Computed Tomography Imaging Market by Segment, U.S., 2006 – 2016
Figure 5-3: Total Computed Tomography Imaging Market, U.S., 2006 – 2016
Figure 5-4: 16/20 Slice Computed Tomography Market, U.S., 2006 – 2016
Figure 5-5: 32/40 Slice Computed Tomography Market, U.S., 2006 – 2016
Figure 5-6: 64 Slice Computed Tomography Market, U.S., 2006 – 2016
Figure 5-7: Ultra Premium Computed Tomography Market, U.S., 2006 – 2016
Figure 5-8: Drivers and Limiters, Computed Tomography Imaging Market, 2009
Figure 5-9: Leading Competitors, Computed Tomography Imaging Market, 2009

NUCLEAR MEDICINE IMAGING MARKET

Figure 6-1: Total Nuclear Medicine Imaging Procedures, U.S., 2006 – 2016
Figure 6-2: Total Nuclear Medicine Imaging Market by Segment, U.S., 2006 – 2016
Figure 6-3: Total Nuclear Medicine Imaging Market, U.S., 2006 – 2016
Figure 6-4: PET/CT Market, U.S., 2006 – 2016
Figure 6-5: SPECT Market, U.S., 2006 – 2016
Figure 6-6: SPECT/CT Market, U.S., 2006 – 2016
Figure 6-7: Drivers and Limiters, Nuclear Medicine Imaging Market, 2009
Figure 6-8: Leading Competitors, Nuclear Medicine Imaging Market, 2009

CONTRAST AGENT AND INJECTOR MARKET

Figure 7-1: Total Contrast Agent and Injector Market by Segment, U.S., 2006 – 2016
Figure 7-2: Total Contrast Agent Market, U.S., 2006 – 2016
Figure 7-3: X-Ray/CT Contrast Agent Market, U.S., 2006 – 2016
Figure 7-4: MRI Contrast Agent Market, U.S., 2006 – 2016
Figure 7-5: Ultrasound Contrast Agent Market, U.S., 2006 – 2016
Figure 7-6: Contrast Injector Market, U.S., 2006 – 2016
Figure 7-7: Drivers and Limiters, Contrast Agent Market, 2009
Figure 7-8: Leading Competitors, Contrast Agent and Injector Market, 2009

ABBREVIATIONS

LIST OF CHARTS

EXECUTIVE SUMMARY

Chart 1-1: MRI, CT and Nuclear Medicine Market, U.S., 2006 – 2016
Chart 1-2: Low-Field Magnetic Resonance Imaging Average Selling Price, U.S., 2006 – 2016
Chart 1-3: Unit Sales and Installed Base of Intra-Operative Magnetic Resonance Imaging Systems, U.S., 2006 – 2016
Chart 1-4: MRI Units Sold by Segment, U.S., 2006 – 2016
Chart 1-5: Contrast Agent Procedures, U.S., 2006 – 2016
Chart 1-6: Leading Competitors, MRI, CT and Nuclear Medicine Market, U.S., 2009

RESEARCH METHODOLOGY

U.S. MAGNETIC RESONANCE IMAGING, COMPUTED TOMOGRAPHY AND NUCLEAR MEDICINE MARKET

Chart 3-1: Total MRI, CT and Nuclear Medicine Market, U.S., 2006 – 2016
Chart 3-2: MRI, CT and Nuclear Medicine Market by Segment, U.S., 2006 – 2016
Chart 3-3: Total MRI, CT and Nuclear Medicine Market by Segment, U.S., 2009
Chart 3-4: Total MRI, CT and Nuclear Medicine Market by Segment, U.S., 2016
Chart 3-5: Growth Rates by Segment, Total MRI, CT and Nuclear Medicine Market, U.S., 2006 – 2016
Chart 3-6: Leading Competitors, MRI, CT and Nuclear Medicine Market, 2009

MAGNETIC RESONANCE IMAGING MARKET

Chart 4-1: Total Magnetic Resonance Imaging Procedures, U.S., 2006 – 2016
Chart 4-2: Total Magnetic Resonance Imaging Market by Segment, U.S., 2006 – 2016
Chart 4-3: Total Magnetic Resonance Imaging Market by Segment, U.S., 2009
Chart 4-4: Total Magnetic Resonance Imaging Market by Segment, U.S., 2016
Chart 4-5: Total Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Chart 4-6: Low-Field Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Chart 4-7: Mid-Field Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Chart 4-8: High-Field Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Chart 4-9: Open Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Chart 4-10: Intraoperative Magnetic Resonance Imaging Market, U.S., 2006 – 2016
Chart 4-11: Leading Competitors, Magnetic Resonance Imaging Market, 2009

COMPUTED TOMOGRAPHY IMAGING MARKET

Chart 5-1: Total Computed Tomography Procedures, U.S., 2006 – 2016
Chart 5-2: Total Computed Tomography Imaging Market by Segment, U.S., 2006 – 2016
Chart 5-3: Total Computed Tomography Imaging Market by Segment, U.S., 2009
Chart 5-4: Total Computed Tomography Imaging Market by Segment, U.S., 2016
Chart 5-5: Total Computed Tomography Imaging Market, U.S., 2006 – 2016
Chart 5-6: 16/20 Slice Computed Tomography Market, U.S., 2006 – 2016
Chart 5-7: 32/40 Slice Market, Computed Tomography Market, U.S., 2006 – 2016
Chart 5-8: 64 Slice Computed Tomography Market, U.S., 2006 – 2016
Chart 5-9: Ultra Premium Computed Tomography Market, U.S., 2006 – 2016
Chart 5-10: Leading Competitors, Computed Tomography Market, 2009

NUCLEAR MEDICINE IMAGING MARKET

Chart 6-1: Total Nuclear Medicine Imaging Procedures, U.S., 2006 – 2016
Chart 6-2: Total Nuclear Medicine Imaging Market by Segment, U.S., 2006 – 2016
Chart 6-3: Total Nuclear Medicine Imaging Market by Segment, U.S., 2009
Chart 6-4: Total Nuclear Medicine Imaging Market by Segment, U.S., 2016
Chart 6-5: Total Nuclear Medicine Imaging Market, U.S., 2006 – 2016
Chart 6-6: PET/CT Market, U.S., 2006 – 2016
Chart 6-7: SPECT Market, U.S., 2006 – 2016
Chart 6-8: SPECT/CT Market, U.S., 2006 – 2016
Chart 6-9: Leading Competitors, Nuclear Medicine Imaging Market, 2009

CONTRAST AGENT AND INJECTOR MARKET

Chart 7-1: Total Contrast Agent and Injector Market by Segment, U.S., 2006 – 2016
Chart 7-2: Total Contrast Agent and Injector Market by Segment, U.S., 2009
Chart 7-3: Total Contrast Agent Market and Injector by Segment, U.S., 2016
Chart 7-4: Total Contrast Agent Market, U.S., 2006 – 2016
Chart 7-5: X-Ray/CT Contrast Agent Market, U.S., 2006 – 2016
Chart 7-6: MRI Contrast Agent Market, U.S., 2006 – 2016
Chart 7-7: Ultrasound Contrast Agent Market, U.S., 2006 – 2016
Chart 7-8: Contrast Injector Market, U.S., 2006 – 2016
Chart 7-9: Leading Competitors, Contrast Agent and Injector Market, 2009

ABBREVIATIONS
Skip to top


Ask Your Question

U.S. Market for Magnetic Resonance, Computed Tomography and Nuclear Medicine 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: